Evidence map›Paper›PMID 37790988›Full record

ArticleJournal of multidisciplinary healthcare2023

Aggressiveness of Cancer Care at End of Life in Patients with Metastatic Breast Cancer in Jordan.

Mahmoud Abunasser, Hala Abu-Fares, Sarah Abdel-Razeq, Omar Shamieh, Osama Salama, Khaled Ashouri, Abdullah Al Qudah, Ayat Taqash, Hala Abu-Jaish, Salwa S Saadah and 1 more

Abstract read
In one paragraph

Article in Journal of multidisciplinary healthcare, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mahmoud AbunasserDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0002-8682-227X
Hala Abu-FaresDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Sarah Abdel-RazeqSchool of Medicine, the University of Jordan, Amman, Jordan.
Omar ShamiehSchool of Medicine, the University of Jordan, Amman, Jordan.
Osama SalamaDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Khaled AshouriDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Abdullah Al QudahDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0002-1880-6972
Ayat TaqashOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0002-1046-8622
Hala Abu-JaishSchool of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Salwa S SaadahDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0002-1052-9093
Hikmat Abdel-RazeqDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0003-2833-6051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Contrary to Western societies, more than 15% of patients with breast cancer in Jordan are diagnosed with stage IV disease. In this study, we evaluate the value of early palliative care integration in the end-of-life care of such patients. Methods: All consecutive adult patients who died between 2014 to 2018, while under the care of our institution, with a confirmed diagnosis of breast cancer at the time of death, irrespective of place of death, were retrospectively reviewed. Results: During the study period, a total of 433 patients, median age 51.6 years, were included in the analysis. Among the whole group, 102 (23.6%) were referred to palliative care service early (≥30 days prior to death), 182 (42.0%) had late referral (<30 days from death), while 149 (34.4%) were never referred and were followed up by their medical oncologists. During the last 30 days prior to death, patients who were never referred to palliative care were more likely to visit the Emergency Room (ER) more than once (OR 1.89, 95% CI 1.20-2.99, p = 0.006), more likely to be admitted to the hospital more than once (OR 2.27, 95% CI 1.38-3.73, p = 0.001), and more likely to be admitted to the intensive care unit (ICU) (OR 3.07, 95% CI 1.48-6.38, p = 0.0027). Fewer patients in the "no referral" group died with advance directives compared to those who had early or late referral; 60.8%, 75.0% and 82.5%, respectively, p = 0.0003. Survival of patients followed by medical oncologist was not better than those referred to palliative care, either late or early; median survival was 19.0, 19.1 and 23.8 months, respectively (p = 0.2338). Conclusion: Findings suggest that earlier palliative care referral is associated with less aggressive end-of-life care, leading to less frequent ER visits, hospital and ICU admissions during the last month of life, and does not compromise survival.

Indexed as

DNRDo not resuscitateend-of-lifemetastatic breast cancerpalliative care

Identifiers

PMID37790988
PMCPMC10543079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.